Labroots and the Drug Discovery planning committee are pleased to announce the 5th annual event in the Drug Discovery & Development Virtual Event Series. Labroots will host this online-only event on February 23, 2022. The Drug Discovery planning committee will invite speakers from industry and academia to discuss key challenges, new opportunities, and recent successes in the current landscape of drug discovery and development.
The tracks include:
- Novel Approaches to Drug Discovery and Preclinical Development
- Emerging Assays
- Patient-derived Organoid Models
- Systems to Predict Safety and Efficacy
- Explorations into PK/PD and Pharmacogenomics
- PGX of GPCRs
- In-vitro Models of Toxicity
- Advancements in Clinical Development
- Health Equality and Genetic Diversity in Clinical Trials
- Innovations in Biomarkers
- Digital Solutions
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2022 Drug Discovery & Development Virtual Event. Submission is free. Submit your abstract here.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global drug discovery community with a high degree of interaction through live-streaming video and chat sessions.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Use #LRdrug to follow the conversation!